Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2025 Filed Jan 7, 2025 21:42 UTC |
MAY PETER WDirector · 10% owner
|
GrantCommon Stock | 1,880 | $17.22 | $32,373.60 |
DisclosureSEC source: 0000950170-25-002906 · ownership.xml · nonDerivative · entry 1 MAY PETER W · CIK 0000928264 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,510,666 F1 · acquired: Shares were issued pursuant to the Company's 2020 Omnibus Award Plan (the "Plan") in lieu of a quarterly Board of Directors retainer fee and a quarterly Board committee retainer fee that would otherwise be payable in cash. In accordance with the Plan, the price is the average of the closing price per share on the 20 consecutive trading days immediately preceding the date on which the retainer fees would otherwise be payable. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 21:42 UTC |
Dolan Kristin ADirector
|
GrantCommon Stock | 702 | $17.22 | $12,088.44 |
DisclosureSEC source: 0001127602-25-000922 · form4.xml · nonDerivative · entry 1 Dolan Kristin A · CIK 0001480991 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,829 F1 · kind: Shares were issued pursuant to the Company's 2020 Omnibus Award Plan (the "Plan") in lieu of a portion of Ms. Dolan's quarterly Board of Directors retainer fee and quarterly Board committee retainer fees that would otherwise be payable in cash. In accordance with the Plan, the price is the average of the closing price per share on the 20 consecutive trading days immediately preceding the date on which the retainer fees would otherwise be payable. Read SEC document |
| December 18, 2024 Filed Dec 19, 2024 22:02 UTC |
Thuerk Suzanne M.Chief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 17,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029812 · form4.xml · derivative · entry 1 Thuerk Suzanne M. · CIK 0001963800 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,530 Underlying: Common Stock · 17,985 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: The restricted stock units will vest in full on December 18, 2027, subject to Ms. Thuerk's continued employment with the Company on the vesting date. F3 · derivative.expiration_date: The restricted stock units will vest in full on December 18, 2027, subject to Ms. Thuerk's continued employment with the Company on the vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:48 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 436 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029746 · form4.xml · derivative · entry 6 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,612 Underlying: Common Stock · 436 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F9 · derivative.exercise_date: The restricted stock units will vest in full on August 15, 2027, subject to Ms. Radkoski's continued employment with the Company on the vesting date. F9 · derivative.expiration_date: The restricted stock units will vest in full on August 15, 2027, subject to Ms. Radkoski's continued employment with the Company on the vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:48 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 110 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029746 · form4.xml · derivative · entry 5 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,176 Underlying: Common Stock · 110 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F8 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 15, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. F8 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 15, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:48 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 43 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029746 · form4.xml · derivative · entry 4 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,066 Underlying: Common Stock · 43 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F7 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. F7 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:48 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 121 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029746 · form4.xml · derivative · entry 3 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,023 Underlying: Common Stock · 121 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F6 · derivative.exercise_date: The restricted stock units will vest in three equal installments on December 7, 2024, 2025 and 2026, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. F6 · derivative.expiration_date: The restricted stock units will vest in three equal installments on December 7, 2024, 2025 and 2026, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:48 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 16 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029746 · form4.xml · derivative · entry 2 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,902 Underlying: Common Stock · 16 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F5 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:48 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029746 · form4.xml · derivative · entry 1 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,886 Underlying: Common Stock · 69 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in full on August 12, 2025, subject to Ms. Radkoski's continued employment with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in full on August 12, 2025, subject to Ms. Radkoski's continued employment with the Company on the vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:46 UTC |
GILBERT KENNETH WDirector
|
GrantRestricted Stock Units · Derivative | 138 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029744 · form4.xml · derivative · entry 2 GILBERT KENNETH W · CIK 0001120304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,759 Underlying: Common Stock · 138 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F2 · shares: Represents dividend equivalent units issued on December 16, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in full on the earlier of May 21, 2025 or the date of the Company's 2025 annual meeting of stockholders. Vested shares will be delivered upon Mr. Gilbert's termination as a director of the Company. F4 · derivative.expiration_date: The restricted stock units will vest in full on the earlier of May 21, 2025 or the date of the Company's 2025 annual meeting of stockholders. Vested shares will be delivered upon Mr. Gilbert's termination as a director of the Company. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:46 UTC |
GILBERT KENNETH WDirector
|
GrantRestricted Stock Units · Derivative | 106 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029744 · form4.xml · derivative · entry 1 GILBERT KENNETH W · CIK 0001120304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,621 Underlying: Common Stock · 106 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F2 · shares: Represents dividend equivalent units issued on December 16, 2024. F3 · derivative.exercise_date: The restricted stock units vested in full on May 16, 2024. Vested shares will be delivered upon Mr. Gilbert's termination as a director of the Company. F3 · derivative.expiration_date: The restricted stock units vested in full on May 16, 2024. Vested shares will be delivered upon Mr. Gilbert's termination as a director of the Company. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:43 UTC |
Tanner KirkDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029742 · form4.xml · derivative · entry 2 Tanner Kirk · CIK 0001671693 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 408,985 Underlying: Common Stock · 809 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. Tanner's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. Tanner's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:43 UTC |
Tanner KirkDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 5,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029742 · form4.xml · derivative · entry 1 Tanner Kirk · CIK 0001671693 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 408,176 Underlying: Common Stock · 5,157 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in full in three equal installments on February 22, 2025, 2026 and 2027, subject to Mr. Tanner's continued employment with the Company on the applicable vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in full in three equal installments on February 22, 2025, 2026 and 2027, subject to Mr. Tanner's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:41 UTC |
Arlin Wendy C.Director
|
GrantRestricted Stock Units · Derivative | 138 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029740 · form4.xml · derivative · entry 1 Arlin Wendy C. · CIK 0001876592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,513 Underlying: Common Stock · 138 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F2 · shares: Represents dividend equivalent units issued on December 16, 2024. F3 · derivative.exercise_date: The restricted stock units will vest in full on the earlier of May 21, 2025 or the date of the Company's 2025 annual meeting of stockholders. Vested shares will be delivered upon Ms. Arlin's termination as a director of the Company. F3 · derivative.expiration_date: The restricted stock units will vest in full on the earlier of May 21, 2025 or the date of the Company's 2025 annual meeting of stockholders. Vested shares will be delivered upon Ms. Arlin's termination as a director of the Company. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:38 UTC |
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
|
GrantRestricted Stock Units · Derivative | 91 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029738 · form4.xml · derivative · entry 2 Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,391 Underlying: Common Stock · 91 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027 subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027 subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:38 UTC |
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
|
GrantRestricted Stock Units · Derivative | 46 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029738 · form4.xml · derivative · entry 1 Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,300 Underlying: Common Stock · 46 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:36 UTC |
O'Brien Matthew ColeyChief People Officer
|
GrantRestricted Stock Units · Derivative | 105 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029734 · form4.xml · derivative · entry 3 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,208 Underlying: Common Stock · 105 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F6 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. F6 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:36 UTC |
O'Brien Matthew ColeyChief People Officer
|
GrantRestricted Stock Units · Derivative | 51 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029734 · form4.xml · derivative · entry 2 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,103 Underlying: Common Stock · 51 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F5 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:36 UTC |
O'Brien Matthew ColeyChief People Officer
|
GrantRestricted Stock Units · Derivative | 255 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029734 · form4.xml · derivative · entry 1 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,052 Underlying: Common Stock · 255 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in full on March 1, 2026, subject to Mr. O'Brien's continued employment with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in full on March 1, 2026, subject to Mr. O'Brien's continued employment with the Company on the vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:33 UTC |
Pringle Abigail E.President, U.S.
|
GrantRestricted Stock Units · Derivative | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029732 · form4.xml · derivative · entry 2 Pringle Abigail E. · CIK 0001676101 · President, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,344 Underlying: Common Stock · 263 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:33 UTC |
Pringle Abigail E.President, U.S.
|
GrantRestricted Stock Units · Derivative | 121 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029732 · form4.xml · derivative · entry 1 Pringle Abigail E. · CIK 0001676101 · President, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,081 Underlying: Common Stock · 121 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:32 UTC |
Spessard Matthew PChief Information Officer
|
GrantRestricted Stock Units · Derivative | 47 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029730 · form4.xml · derivative · entry 2 Spessard Matthew P · CIK 0002014323 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,370 Underlying: Common Stock · 47 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:32 UTC |
Spessard Matthew PChief Information Officer
|
GrantRestricted Stock Units · Derivative | 16 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029730 · form4.xml · derivative · entry 1 Spessard Matthew P · CIK 0002014323 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,323 Underlying: Common Stock · 16 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. Spessard's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:30 UTC |
Thuerk Suzanne M.Chief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 27 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029728 · form4.xml · derivative · entry 3 Thuerk Suzanne M. · CIK 0001963800 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,545 Underlying: Common Stock · 27 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F6 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Thuerk's continued employment with the Company on the applicable vesting date. F6 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Thuerk's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:30 UTC |
Thuerk Suzanne M.Chief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029728 · form4.xml · derivative · entry 2 Thuerk Suzanne M. · CIK 0001963800 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,518 Underlying: Common Stock · 11 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F5 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Thuerk's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Thuerk's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:30 UTC |
Thuerk Suzanne M.Chief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 57 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029728 · form4.xml · derivative · entry 1 Thuerk Suzanne M. · CIK 0001963800 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,507 Underlying: Common Stock · 57 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in full on August 12, 2025, subject to Ms. Thuerk's continued employment with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in full on August 12, 2025, subject to Ms. Thuerk's continued employment with the Company on the vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:28 UTC |
Wunsch E.J.President, International
|
GrantRestricted Stock Units · Derivative | 219 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029726 · form4.xml · derivative · entry 2 Wunsch E.J. · CIK 0001685884 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,567 Underlying: Common Stock · 219 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. Wunsch's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. Wunsch's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:28 UTC |
Wunsch E.J.President, International
|
GrantRestricted Stock Units · Derivative | 81 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029726 · form4.xml · derivative · entry 1 Wunsch E.J. · CIK 0001685884 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,348 Underlying: Common Stock · 81 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. Wunsch's continued employment with the Company on the applicable vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. Wunsch's continued employment with the Company on the applicable vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:26 UTC |
Min JohnChief Legal Ofcr & Secretary
|
GrantRestricted Stock Units · Derivative | 208 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029724 · form4.xml · derivative · entry 1 Min John · CIK 0001994515 · Chief Legal Ofcr & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,308 Underlying: Common Stock · 208 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in full on September 16, 2027, subject to Mr. Min's continued employment with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in full on September 16, 2027, subject to Mr. Min's continued employment with the Company on the vesting date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:24 UTC |
Cook Kenneth M.Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 245 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-029722 · form4.xml · derivative · entry 1 Cook Kenneth M. · CIK 0002046945 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,856 Underlying: Common Stock · 245 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on December 16, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in full on December 2, 2027, subject to Mr. Cook's continued employment with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in full on December 2, 2027, subject to Mr. Cook's continued employment with the Company on the vesting date. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:56 UTC |
Cook Kenneth M.Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 16,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-028651 · form4.xml · derivative · entry 1 Cook Kenneth M. · CIK 0002046945 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,611 Underlying: Common Stock · 16,611 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: The restricted stock units will vest in full on December 2, 2027, subject to Mr. Cook's continued employment with the Company on the vesting date. F3 · derivative.expiration_date: The restricted stock units will vest in full on December 2, 2027, subject to Mr. Cook's continued employment with the Company on the vesting date. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 21:46 UTC |
Mathews-Spradlin Mich JDirector
|
SaleCommon Stock | 24,462 | $20.28 | $496,089.36 |
DisclosureSEC source: 0001127602-24-026851 · form4.xml · nonDerivative · entry 1 Mathews-Spradlin Mich J · CIK 0001635074 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,789 Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 22:02 UTC |
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 52,009 | $0.00 Strike: $15.36 | $0.00 |
DisclosureSEC source: 0001127602-24-026738 · form4.xml · derivative · entry 3 Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,009 shares Expires 2027-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: With tandem net exercise and tax withholding rights. F2 · derivative.exercise_date: The option vested in three equal installments on August 11, 2018, 2019 and 2020 and is currently exercisable as to all 52,009 remaining shares. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 22:02 UTC |
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
|
SaleCommon Stock | 52,009 | $19.63 | $1,020,936.67 |
DisclosureSEC source: 0001127602-24-026738 · form4.xml · nonDerivative · entry 2 Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,492 Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 22:02 UTC |
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
|
Exercise / conversionCommon Stock | 52,009 | $15.36 | $798,598.20 |
DisclosureSEC source: 0001127602-24-026738 · form4.xml · nonDerivative · entry 1 Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 20:46 UTC |
Dolan Kristin ADirector
|
GrantCommon Stock | 813 | $17.28 | $14,048.64 |
DisclosureSEC source: 0001127602-24-025290 · form4.xml · nonDerivative · entry 1 Dolan Kristin A · CIK 0001480991 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,127 F1 · kind: Shares were issued pursuant to the Company's 2020 Omnibus Award Plan (the "Plan") in lieu of a portion of Ms. Dolan's quarterly Board of Directors retainer fee and quarterly Board committee retainer fees that would otherwise be payable in cash. In accordance with the Plan, the price is the average of the closing price per share on the 20 consecutive trading days immediately preceding the date on which the retainer fees would otherwise be payable. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 20:46 UTC |
Peltz Matthew H.Director · 10% owner
|
GrantCommon Stock | 1,569 | $17.28 | $27,112.32 |
DisclosureSEC source: 0000950170-24-113274 · ownership.xml · nonDerivative · entry 1 Peltz Matthew H. · CIK 0001661127 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,334 F1 · acquired: Shares were issued pursuant to the Company's 2020 Omnibus Award Plan (the "Plan") in lieu of a quarterly Board of Directors retainer fee and a quarterly Board committee retainer fee that would otherwise be payable in cash. In accordance with the Plan, the price is the average of the closing price per share on the 20 consecutive trading days immediately preceding the date on which the retainer fees would otherwise be payable. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 20:45 UTC |
MAY PETER WDirector · 10% owner
|
GrantCommon Stock | 1,757 | $17.28 | $30,360.96 |
DisclosureSEC source: 0000950170-24-113268 · ownership.xml · nonDerivative · entry 1 MAY PETER W · CIK 0000928264 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,508,786 F1 · acquired: Shares were issued pursuant to the Company's 2020 Omnibus Award Plan (the "Plan") in lieu of a quarterly Board of Directors retainer fee and a quarterly Board committee retainer fee that would otherwise be payable in cash. In accordance with the Plan, the price is the average of the closing price per share on the 20 consecutive trading days immediately preceding the date on which the retainer fees would otherwise be payable. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 21:01 UTC |
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
|
GrantRestricted Stock Units · Derivative | 85 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024257 · form4.xml · derivative · entry 2 Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,254 Underlying: Common Stock · 85 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on September 17, 2024. F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 21:01 UTC |
Esposito LilianaChf Corp Affrs & Sustnblty Ofc
|
GrantRestricted Stock Units · Derivative | 43 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024257 · form4.xml · derivative · entry 1 Esposito Liliana · CIK 0001609772 · Chf Corp Affrs & Sustnblty Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,169 Underlying: Common Stock · 43 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on September 17, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Esposito's continued employment with the Company on the applicable vesting date. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 20:59 UTC |
Plosch GuntherChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024255 · form4.xml · derivative · entry 2 Plosch Gunther · CIK 0001673498 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,497 Underlying: Common Stock · 240 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on September 17, 2024. F5 · derivative.exercise_date: The restricted stock units will vest in full in three equal installments on August 5, 2025, 2026 and 2027 subject to Mr. Plosch's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in full in three equal installments on August 5, 2025, 2026 and 2027 subject to Mr. Plosch's continued employment with the Company on the applicable vesting date. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 20:59 UTC |
Plosch GuntherChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024255 · form4.xml · derivative · entry 1 Plosch Gunther · CIK 0001673498 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,257 Underlying: Common Stock · 128 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on September 17, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. Plosch's continued employment with the Company on the applicable vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. Plosch's continued employment with the Company on the applicable vesting date. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 21:00 UTC |
O'Brien Matthew ColeyChief People Officer
|
GrantRestricted Stock Units · Derivative | 97 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024256 · form4.xml · derivative · entry 3 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,797 Underlying: Common Stock · 97 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on September 17, 2024. F6 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. F6 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 21:00 UTC |
O'Brien Matthew ColeyChief People Officer
|
GrantRestricted Stock Units · Derivative | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024256 · form4.xml · derivative · entry 2 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,700 Underlying: Common Stock · 48 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on September 17, 2024. F5 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Mr. O'Brien's continued employment with the Company on the applicable vesting date. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 21:00 UTC |
O'Brien Matthew ColeyChief People Officer
|
GrantRestricted Stock Units · Derivative | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024256 · form4.xml · derivative · entry 1 O'Brien Matthew Coley · CIK 0001732939 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,652 Underlying: Common Stock · 240 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on September 17, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in full on March 1, 2026, subject to Mr. O'Brien's continued employment with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in full on March 1, 2026, subject to Mr. O'Brien's continued employment with the Company on the vesting date. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 20:58 UTC |
Pringle Abigail E.President, U.S.
|
GrantRestricted Stock Units · Derivative | 246 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024254 · form4.xml · derivative · entry 2 Pringle Abigail E. · CIK 0001676101 · President, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,960 Underlying: Common Stock · 246 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on September 17, 2024. F5 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date. F5 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 20:58 UTC |
Pringle Abigail E.President, U.S.
|
GrantRestricted Stock Units · Derivative | 114 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024254 · form4.xml · derivative · entry 1 Pringle Abigail E. · CIK 0001676101 · President, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,714 Underlying: Common Stock · 114 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on September 17, 2024. F4 · derivative.exercise_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date. F4 · derivative.expiration_date: The restricted stock units will vest in two remaining equal installments on August 11, 2025 and 2026, subject to Ms. Pringle's continued employment with the Company on the applicable vesting date. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 20:56 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 409 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024253 · form4.xml · derivative · entry 6 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,817 Underlying: Common Stock · 409 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on September 17, 2024. F9 · derivative.exercise_date: The restricted stock units will vest in full on August 15, 2027, subject to Ms. Radkoski's continued employment with the Company on the vesting date. F9 · derivative.expiration_date: The restricted stock units will vest in full on August 15, 2027, subject to Ms. Radkoski's continued employment with the Company on the vesting date. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 20:56 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 102 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024253 · form4.xml · derivative · entry 5 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,408 Underlying: Common Stock · 102 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on September 17, 2024. F8 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 15, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. F8 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 15, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 20:56 UTC |
Radkoski Lindsay J.CMO, U.S.
|
GrantRestricted Stock Units · Derivative | 41 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024253 · form4.xml · derivative · entry 4 Radkoski Lindsay J. · CIK 0002034276 · CMO, U.S. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,306 Underlying: Common Stock · 41 shares Expires not disclosed F1 · security: With tandem dividend equivalent rights and tax withholding rights. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · shares: Represents dividend equivalent units issued on September 17, 2024. F7 · derivative.exercise_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. F7 · derivative.expiration_date: The restricted stock units will vest in three equal installments on August 5, 2025, 2026 and 2027, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.